Oxford Biomedica Plc (OXBDF)
6.65
0.00 (0.00%)
USD |
OTCM |
Oct 01, 16:00
Oxford Biomedica Market Cap : 804.69M for Oct. 1, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 01, 2026 | 804.69M |
| September 30, 2026 | 804.69M |
| September 29, 2026 | 804.69M |
| September 28, 2026 | 804.69M |
| September 25, 2026 | 804.69M |
| September 24, 2026 | 776.86M |
| September 23, 2026 | 776.86M |
| September 22, 2026 | 799.85M |
| September 21, 2026 | 725.63M |
| September 18, 2026 | 725.63M |
| September 17, 2026 | 725.63M |
| September 16, 2026 | 723.92M |
| September 15, 2026 | 770.20M |
| September 14, 2026 | 711.05M |
| September 11, 2026 | 711.41M |
| September 10, 2026 | 703.80M |
| September 09, 2026 | 742.43M |
| September 08, 2026 | 863.16M |
| September 04, 2026 | 863.16M |
| September 03, 2026 | 863.16M |
| September 02, 2026 | 863.16M |
| September 01, 2026 | 863.16M |
| August 31, 2026 | 863.16M |
| August 28, 2026 | 863.16M |
| August 27, 2026 | 863.16M |
| Date | Value |
|---|---|
| August 26, 2026 | 863.16M |
| August 25, 2026 | 869.19M |
| August 24, 2026 | 869.19M |
| August 21, 2026 | 841.96M |
| August 20, 2026 | 841.96M |
| August 19, 2026 | 830.56M |
| August 18, 2026 | 830.56M |
| August 17, 2026 | 830.56M |
| August 14, 2026 | 830.56M |
| August 13, 2026 | 886.09M |
| August 12, 2026 | 886.09M |
| August 11, 2026 | 886.09M |
| August 10, 2026 | 886.09M |
| August 07, 2026 | 886.09M |
| August 06, 2026 | 886.09M |
| August 05, 2026 | 886.09M |
| August 04, 2026 | 886.09M |
| August 03, 2026 | 965.77M |
| July 31, 2026 | 965.77M |
| July 30, 2026 | 965.77M |
| July 29, 2026 | 965.77M |
| July 28, 2026 | 965.77M |
| July 27, 2026 | 965.77M |
| July 24, 2026 | 965.77M |
| July 23, 2026 | 965.77M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Bicycle Therapeutics Plc | 170.27M |
| Roivant Sciences Ltd. | 25.82B |
| Adaptimmune Therapeutics Plc | 10.07M |
| Kiniksa Pharmaceuticals International Plc | 5.905B |
| Autolus Therapeutics Plc | 472.44M |
Market Cap Related Metrics
| PS Ratio | 3.416 |
| Price | 6.65 |
| Earnings Yield | -6.81% |